| Sharena Lightfoot, LMT, LPN | |
|
1911 Westmead Dr Apt 2305, Houston, TX 77077-4717 | |
| (985) 709-7955 | |
| Not Available |
| Full Name | Sharena Lightfoot |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 1911 Westmead Dr Apt 2305, Houston, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043988827 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 20170679 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sharena Lightfoot, LMT, LPN 712 Wilcrest Dr Ste 171, Houston, TX 77042-1348 Ph: (985) 709-7955 | Sharena Lightfoot, LMT, LPN 1911 Westmead Dr Apt 2305, Houston, TX 77077-4717 Ph: (985) 709-7955 |
News Archive
UCSF researchers have discovered that a key cellular defect that disturbs the production of proteins in human cells can lead to cancer susceptibility. The scientists also found that a new generation of inhibitory drugs offers promise in correcting this defect.
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the U.S. Food and Drug Administration (FDA) has extended the PDUFA goal date for its review of the New Drug Application (NDA) for Fampridine-SR to January 22, 2010. The original Prescription Drug User Fee Act (PDUFA) date for this priority review application was October 22, 2009.
How the virus does this was unknown until now. The scientists from the HZI research group "Viral Immune Modulation" under the leadership of Prof. Melanie Brinkmann have now been able to show that the virus is actively preventing activation of the innate immune system through Toll-like receptors.
A new diagnostic tool developed by Van Andel Research Institute (VARI) scientists has shown promising results when used with patients of pancreatic cancer, one of the deadliest forms of cancer due to the difficulty of diagnosing it in its early stages. The method, which studies carbohydrate structures in the bloodstream, could lead to the development of blood tests that can detect cancer more effectively.
Scientists have found a way to target elusive cells that suppress immune response, depleting them with peptides that spare other important cells and shrink tumors in preclinical experiments, according to a paper published online by Nature Medicine.
› Verified 4 days ago
Chawntel Rene Walker-carter, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 7514 San Dimas Sr, Houston, TX 77083 Phone: 832-620-0096 | |
Shelbie Shelton, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 10427 Huntington Estates Dr, Houston, TX 77099 Phone: 337-351-9670 | |
Karsyn Bemis, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1155 Dairy Ashford Rd Ste 209, Houston, TX 77079 Phone: 713-799-2200 | |
Mrs. Moriam O Oshikoya, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2424 Wilcrest Dr Ste 110, Houston, TX 77042 Phone: 713-666-8287 Fax: 713-660-8391 | |
Nayeli Esther Hamann, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 17122 Plaistow Ct, Houston, TX 77084 Phone: 605-237-5753 | |
Benadeth Onyinyechi Geoffrey, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 12939 Whittington Dr, Houston, TX 77077 Phone: 346-288-9967 |